NCT03917186View on ClinicalTrials.gov

Desflurane vs. Sevoflurane in Endovascular Aortic Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

March 16, 2021

Conditions
Renal Failure
Interventions
DRUG

Sevoflurane

administration of sevoflurane

DRUG

Desflurane

administration of Desflurane

Trial Locations (1)

28007

Hospital general universitario Gregorio Marañón, Madrid

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Begoña Quintana Villamandos

OTHER

NCT03917186 - Desflurane vs. Sevoflurane in Endovascular Aortic Repair | Biotech Hunter | Biotech Hunter